A detailed history of Lpl Financial LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 51,660 shares of ABEO stock, worth $320,292. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,660
Previous 50,985 1.32%
Holding current value
$320,292
Previous $216,000 50.93%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$4.12 - $6.32 $2,781 - $4,266
675 Added 1.32%
51,660 $326,000
Q2 2024

Aug 07, 2024

BUY
$3.17 - $8.05 $64,810 - $164,582
20,445 Added 66.94%
50,985 $216,000
Q1 2024

May 10, 2024

BUY
$4.07 - $8.68 $4,884 - $10,416
1,200 Added 4.09%
30,540 $221,000
Q4 2023

Feb 14, 2024

BUY
$3.71 - $5.14 $18,141 - $25,134
4,890 Added 20.0%
29,340 $146,000
Q3 2023

Nov 13, 2023

BUY
$2.98 - $4.43 $72,861 - $108,313
24,450 New
24,450 $102,000

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $36.9M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.